Subclinical intramammary infection does not affect bovine milk ethanol stability / Infecção intramamária subclínica não afeta a estabilidade do leite bovino

The present study hypothesized that intramammary infection (IMI) might reduce milk ethanol stability (MES), mainly when IMI is caused by major pathogens. Thus, this study evaluated the effect of IMI on bovine MES using a natural exposure experimental design. Ninety-four lactating cows from five dairy herds were selected once they were determined to have an IMI, based on milk bacteriological culturing with positive isolation and somatic cell count (SCC) > 200×103 cells/mL in two out of three composite milk samples collected during three consecutive weeks. After selection, cows were sampled a second time (within two weeks) for evaluation at mammary quarter level (n = 326): milk yield (kg/quarter/day), MES, composition (fat, protein, lactose, casein, total solids and solids-non-fat), and bacteriologic culture. The effect of subclinical mastitis on MES was tested by two models: 1) comparison of healthy vs. infected quarters; and 2) comparison of contralateral mammary quarter within cow. The only milk composition variable associated with MES was lactose (r = 0.18; P < 0.01). Subclinical IMI did not affect MES when the comparison was performed using both models (1 and 2). Likewise, MES did not change when infected quarters were sorted into two groups of pathogens (major, minor and infrequent; and contagious, environmental, minor and infrequent) and compared with healthy mammary quarters. Considering the results of both models, subclinical IMI did not affect MES of dairy cows.(AU)

Neste trabalho investigou-se a hipótese de que a infecção intramamária (IIM) poderia reduzir a estabilidade do leite ao etanol (ELA), principalmente quando a IIM é causada por agentes primários. Assim, em um experimento de exposição natural, foi avaliado o efeito da IIM sobre a ELA em bovinos. Noventa e quatro vacas em lactação de cinco rebanhos leiteiros foram selecionadas por apresentar IIM, segundo resultados de cultura bacteriológica de amostras compostas de leite (isolamento positivo) e contagem de células somáticas (CCS) > 200×103 células/mL em pelo menos duas de três coletas semanais consecutivas. Após essa seleção, as vacas foram amostradas pela segunda vez (dentro de duas semanas) para avaliação da IIM em amostras de leite coletadas por quarto mamário (n = 326): produção de leite (kg/quarto/dia), ELA, composição (gordura, proteína, lactose, caseína, sólidos totais e sólidos não gordurosos) e cultura bacteriológica. O efeito da mastite subclínica sobre a ELA foi testada por dois modelos: 1) comparação de quarto sadio versus infectado; e 2) comparação de quartos mamários contralaterais. A única variável de composição do leite associada à ELA foi a lactose (r = 0,18; P < 0,01). A IIM subclínica não afetou a ELA quando a comparação foi realizada utilizando-se os dois modelos (1 e 2); bem como a ELA não foi alterada quando os quartos infectados foram classificados em grupos de agentes patogênicos (primários, secundários e infrequentes; ou contagiosos, ambientais, secundários e infrequentes) e comparados com os quartos mamários sadios. Os resultados obtidos com os dois modelos empregados demonstraram que a IIM subclínica não afetou a ELA de vacas leiteiras.(AU)

Downregulation of Orai1 expression in the airway alleviates murine allergic rhinitis

Orai1 is the key subunit of the Ca2+-release-activated Ca2+ channel. Our previous report has demonstrated that Orai1 expression in the airway was upregulated in the ovalbumin (OVA)-induced allergic rhinitis (AR) mouse models. To observe whether inhibition of Orai1 expression in the airway could suppress symptoms in a murine model of AR and to assess the impacts of this inhibition on the responses of local and systemic immunocytes, we administered recombinant lentivirus vectors that encoded shRNA against ORAI1 (lenti-ORAI1) into the nostrils of OVA-sensitized mice before the challenges, and analyzed its effect on allergic responses, as compared with the unsensitized mice and untreated AR mice. Administration of lenti-ORAI1 into the nasal cavity successfully infected cells in the epithelial layer of the nasal mucosa, and significantly decreased the frequencies of sneezing and nasal rubbing of the mice. Protein levels of leukotriene C4, OVA-specific IgE, and IL-4 in the nasal lavage fluid and serum and eosinophil cation protein in the serum were also significantly reduced by lenti-ORAI1, as were the mRNA levels of these factors in the nasal mucosa and spleen. These data suggested that administration of lenti-ORAI1 into the nasal cavity effectively decreased Orai1 expression in the nasal mucosa, alleviated AR symptoms, and partially inhibited the hyperresponsiveness of the local and systemic immune cells including T cells, B cells, mast cells and eosinophils that are involved in the pathogenesis of AR.